Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 23: PICSO-AMI-I: Pressure Controlled Intermittent Coronary Sinus Occlusion in Acute Myocardial Infarction.
Author(s): Giovanni Luigi Di Maria Added: 1 year ago
TCT 23 - We are joined by Dr Giovanni Luigi Di Maria (John Radcliffe Hospital, UK) to discuss the findings of the PICSO-AMI-I study (NCT04958421), sponsored by Miracor Medical. The PICSO-AMI-I study aimed to assess the safety and feasibility of pressure-controlled intermittent coronary sinus occlusion (PiCSO) in patients with ST-elevation myocardial infarction (MI), presenting with TIMI 0 or 1… View more

Intervention
AHA 23 Late-Breaker Discussion: Hypertension Treatment in Nigeria Program
Author(s): Harriette Van Spall , Dike Bevis Ojji Added: 1 year ago
AHA 2023 — Investigator Dr Dike Bevis Ojji (University of Abuja, NG) talks with Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) about the Hypertension Treatment in Nigeria Program (NCT04158154).The aim of this study (Washington University School of Medicine) and employing an interrupted time series design, is to assess the implementation and evaluation of a culturally- and… View more

Prevention & Chronic Conditions
Isabella Tan
Job title: Research Fellow
Personal History Dr Isabella Tan is a software programmer turned cardiovascular research scientist. She is a Research Fellow at the Macquarie Medical School, Macquarie University, Sydney.2 She enjoys watching Japanese anime and reading manga. In addition to English, she speaks Cantonese and Mandarin.1, 4 Academic History In 2003, Dr Tan graduated from the University of New South… View more
Research Area(s) / Expertise: Job title: President, Foundation–Medical Research Institutes, Geneva and Professor, Lebanese University of Medicine, Beirut
Dr Roland Asmar is president of the "Foundation-Medical research Institutes", and past-President of the "Cardiovascular Institute", Paris, France. Prior to this position, he was past president, of the French spoken network of hypertension, and the International Society of Vascular Health. Dr Asmar developed his clinical research activities in different research units at Broussais Hospital and… View more
Resistant Hypertension: An Overview
Author(s): Giacomo Buso , Claudia Agabiti-Rosei , Matteo Lemoli , et al Added: 11 months ago

Prevention & Chronic Conditions
Viewpoint on Arterial Hypertension
Author(s): Maria Lorenza Muiesan Added: 1 month ago

Prevention & Chronic Conditions
ACC 25 Late-Breaking Discussion: The ADVANCE-HTN Trial
Author(s): Harriette Van Spall , Luke Laffin Added: 1 month ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial… View more

Prevention & Chronic Conditions
Author(s): Fatin Fazrina Roslan , Yuexin Yu , Nurul Ain Nasim Mohd Yusof , et al Added: 9 months ago

Anticoagulation
Tricuspid Regurgitation Therapy
Author(s): Qiuyu Martin Zhu , Natalia Berry Added: 1 year ago

Heart Failure
ACC 25 Late-Breaking Discussion: The STRIDE Trial
Author(s): Harriette Van Spall , Marc P Bonaca Added: 1 month ago
ACC 25 - STRIDE shows subcutaneous semaglutide improved walking ability and related quality of life in patients with both type 2 diabetes and peripheral arterial disease (PAD) with intermittent claudication symptoms.Late-Breaker host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Marc Bonaca (University of Colorado School of Medicine, Aurora, CO, US) to discuss the… View more

Vascular Disease and Surgery

Prevention & Chronic Conditions